However, the FDA has approved one cannabis-derived drug and three cannabis-related drugs. These approved products are only available with a prescription from a licensed health care provider. Cannabidiol (CBD) is a compound found in marijuana. CBD is not harmful, meaning it doesn't cause a “high”.
Hemp is defined as any part of the cannabis sativa plant with no more than 0.3% tetrahydrocannabinol (THC), the mind-altering substance in marijuana. Scientists are still learning how CBD affects the body. The Food and Drug Administration (FDA) approved Epidiolex, a drug containing CBD purified from hemp, to help treat rare seizure disorders. The FDA has concluded that this medication is safe and effective for this intended use.
However, other marketed products and uses of CBD may not be approved by the FDA. CBD is not recommended for use during pregnancy. The potential health effects of using CBD products during pregnancy are currently unknown. In animals, high doses of CBD have caused negative effects on developing fetuses.
4 We don't know if CBD is transmitted to a baby through breast milk. Since the negative effects have been associated with the consumption of CBD, people who are breastfeeding are advised to avoid CBD. We don't know the effects of CBD on children's developing brains. If you use products that contain CBD or THC, store them in child-proof containers and out of reach of children.
If you have more questions, contact your health care provider, health department, or local or regional poison control center at 1-800-222-1222 or 911 if it's an emergency. There are a lot of things we don't know about CBD. Currently, we don't know how CBD consumption affects a person over time. Nor do we know how the different modes of CBD are used (smoking, vaping, eating, applying it to the skin, etc.).
Many companies that sell hemp and CBD products also sell products that contain THC. People should be careful not to confuse THC products with hemp or CBD products. Products containing THC can cause psychoactive effects and adverse events. In addition, most CBD products are not regulated by the FDA.
Therefore, consumers should know that products labeled as hemp or CBD may contain other ingredients, such as THC, pesticides, heavy metals, bacteria or fungi. 5 If consumers experience adverse effects from products containing THC or CBD that pose an immediate danger to their health, they should call their local or regional poison control center at 1-800-222-1222 or 911, or seek medical attention at the local emergency room and report the ingredients of the products What has consumed health care providers. You can review and change the way we collect information below. Thank you for taking the time to confirm your preferences.
If you need to go back and make any changes, you can always do so on our Privacy Policy page. The FDA recognizes the significant public interest in cannabis and cannabis-derived compounds, in particular CBD. You may have noticed that cannabidiol (CBD) seems to be available almost everywhere and is marketed as a variety of products including medications, foods, dietary supplements, cosmetics, and animal health products. We see promise in small, specific projects that improve short-term data methods and point to future opportunities to collect and analyze data on CBD products and, potentially, other types of products in the future.
We see an important public health opportunity in the use of novel data sources and rigorous analytical methods to build a stronger scientific evidence base on the safety profile and use of CBD products. In addition to safety risks and unproven claims, the quality of many CBD products may also be in question. While the FDA appreciates the information and commitment of many interested parties on issues related to CBD, there are still many gaps in the evidence. So it's not surprising that the number of CBD-containing products appearing on store shelves has increased rapidly, representing both opportunities and risks.
In view of the regulatory landscape discussed above, an important part of any legal analysis of the proper status of a hemp-derived CBD product, particularly consumer products sold at retail, is necessarily based on the scope and breadth of the claims made in advertising and the product labeling. As part of these actions, the FDA analyzed the chemical content of cannabinoid compounds in some of the products, and it was found that many did not contain the levels of CBD they claimed to contain. . .
Leave Message